SCHEMBL31330522

SCHEMBL31330522

Cc1nc2c(Br)nc(Cl)cc2c(=O)n1CC(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.41
▸ METAP2 P50579 13/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ EGFR P00533 1/20 0.35
▸ CSNK1E P49674 1/20 0.34
▸ CLK1 P49759 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ CLK3 P49761 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ DYRK2 Q92630 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ DYRK4 Q9NR20 1/20 0.34
▸ DYRK1B Q9Y463 1/20 0.34
▸ PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31330439 0.84 HPGD (0.38) ALDH1A1HTTSMN1; SMN2EGFRAKR1B10
SCHEMBL26988300 0.76 EGFR (0.40) ALDH1A1LMNAHTTEGFRAKR1B10
SCHEMBL31278641 0.76 EGFR (0.40) ALDH1A1LMNAHTTEGFRAKR1B10
SCHEMBL31279024 0.72 CYP1A2 (0.38) —
SCHEMBL30784134 0.72 DDR1 (0.38) CNR1METAP2ALDH1A1LMNAHTT
SCHEMBL31330641 0.71 GAA (0.42) ALDH1A1LMNAEGFRCDK9PIK3CA
SCHEMBL31330766 0.71 — —
SCHEMBL31559679 0.71 CSNK1E (0.43) METAP2ALDH1A1LMNASMN1; SMN2CSNK1E
SCHEMBL31330668 0.70 EGFR (0.35) EGFR
SCHEMBL31330465 0.69 GAA (0.46) ALDH1A1SMN1; SMN2EGFRCDK9PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720061-A1 TREM2 AGONISTS F. Hoffmann-La Roche AG (CH) 2026-04-08 — — EP disclosed
WO-2024246018-A1 TREM2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2024-12-05 — — WO disclosed
Send feedback